Non parametric MannWhitney U test were used to determine the differences between groups
In the recent past, GLP-1 drugs have emerged as a promising option
It was an early instance of the "Oprah Effect" that appearing on her show or among her recommendations could lead to almost overnight success
The semaglutide schedule starts at 0.25 mg weekly for four weeks and reaches the 2.4 mg maintenance dose after 16 weeks
Explore the case study: #ClinicalTrials #GLP1 To view or add a comment, sign in Study setup timelines can have a significant impact on the pace of a GLP1 trial, particularly when global logistics, site readiness, and assessment deployment all need to align
Results from the Healthon Weight Loss Program vary depending on the individual, but most patients begin to see noticeable weight loss within the first 4-12 weeks of treatment